Bed-wetting: Approaches to nocturnal enuresis in children

Elizabeth C. Scheffel, Edward M. DeSimone, Michael H. Davidian

Research output: Contribution to specialist publicationArticle

Abstract

Nocturnal enuresis can be frustrating for children and their families as the child ages, but clinical intervention generally is not warranted until the child is 5 to 7 years old. If nocturnal enuresis is left untreated, resolving the problem can become more difficult. A diagnosis of nocturnal enuresis requires careful coordination of both the patient and the family for optimal outcomes and to avoid relapse. Many treatment plans are founded on motivational therapy and enuresis alarms. Desmopressin and imipramine are FDA-approved for the treatment of nocturnal enuresis in patients older than 6 years. Use of these medications requires thorough counseling by a pharmacist to ensure that the family understands that these medications cannot cure nocturnal enuresis, but are used only for symptom treatment.

Original languageEnglish (US)
Pages32-35
Number of pages4
Volume42
No5
Specialist publicationU.S. Pharmacist
StatePublished - May 1 2017

Fingerprint

Nocturnal Enuresis
Deamino Arginine Vasopressin
Imipramine
Wetting
Enuresis
Therapeutics
Pharmacists
Counseling
Recurrence

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmaceutical Science

Cite this

Scheffel, E. C., DeSimone, E. M., & Davidian, M. H. (2017). Bed-wetting: Approaches to nocturnal enuresis in children. U.S. Pharmacist, 42(5), 32-35.

Bed-wetting : Approaches to nocturnal enuresis in children. / Scheffel, Elizabeth C.; DeSimone, Edward M.; Davidian, Michael H.

In: U.S. Pharmacist, Vol. 42, No. 5, 01.05.2017, p. 32-35.

Research output: Contribution to specialist publicationArticle

Scheffel, EC, DeSimone, EM & Davidian, MH 2017, 'Bed-wetting: Approaches to nocturnal enuresis in children' U.S. Pharmacist, vol. 42, no. 5, pp. 32-35.
Scheffel, Elizabeth C. ; DeSimone, Edward M. ; Davidian, Michael H. / Bed-wetting : Approaches to nocturnal enuresis in children. In: U.S. Pharmacist. 2017 ; Vol. 42, No. 5. pp. 32-35.
@misc{dcc9e6ccc2a0474bab03d37cd8e2c6b8,
title = "Bed-wetting: Approaches to nocturnal enuresis in children",
abstract = "Nocturnal enuresis can be frustrating for children and their families as the child ages, but clinical intervention generally is not warranted until the child is 5 to 7 years old. If nocturnal enuresis is left untreated, resolving the problem can become more difficult. A diagnosis of nocturnal enuresis requires careful coordination of both the patient and the family for optimal outcomes and to avoid relapse. Many treatment plans are founded on motivational therapy and enuresis alarms. Desmopressin and imipramine are FDA-approved for the treatment of nocturnal enuresis in patients older than 6 years. Use of these medications requires thorough counseling by a pharmacist to ensure that the family understands that these medications cannot cure nocturnal enuresis, but are used only for symptom treatment.",
author = "Scheffel, {Elizabeth C.} and DeSimone, {Edward M.} and Davidian, {Michael H.}",
year = "2017",
month = "5",
day = "1",
language = "English (US)",
volume = "42",
pages = "32--35",
journal = "U.S. Pharmacist",
issn = "0148-4818",
publisher = "Jobson Publishing Corporation",

}

TY - GEN

T1 - Bed-wetting

T2 - Approaches to nocturnal enuresis in children

AU - Scheffel, Elizabeth C.

AU - DeSimone, Edward M.

AU - Davidian, Michael H.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Nocturnal enuresis can be frustrating for children and their families as the child ages, but clinical intervention generally is not warranted until the child is 5 to 7 years old. If nocturnal enuresis is left untreated, resolving the problem can become more difficult. A diagnosis of nocturnal enuresis requires careful coordination of both the patient and the family for optimal outcomes and to avoid relapse. Many treatment plans are founded on motivational therapy and enuresis alarms. Desmopressin and imipramine are FDA-approved for the treatment of nocturnal enuresis in patients older than 6 years. Use of these medications requires thorough counseling by a pharmacist to ensure that the family understands that these medications cannot cure nocturnal enuresis, but are used only for symptom treatment.

AB - Nocturnal enuresis can be frustrating for children and their families as the child ages, but clinical intervention generally is not warranted until the child is 5 to 7 years old. If nocturnal enuresis is left untreated, resolving the problem can become more difficult. A diagnosis of nocturnal enuresis requires careful coordination of both the patient and the family for optimal outcomes and to avoid relapse. Many treatment plans are founded on motivational therapy and enuresis alarms. Desmopressin and imipramine are FDA-approved for the treatment of nocturnal enuresis in patients older than 6 years. Use of these medications requires thorough counseling by a pharmacist to ensure that the family understands that these medications cannot cure nocturnal enuresis, but are used only for symptom treatment.

UR - http://www.scopus.com/inward/record.url?scp=85019835040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019835040&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85019835040

VL - 42

SP - 32

EP - 35

JO - U.S. Pharmacist

JF - U.S. Pharmacist

SN - 0148-4818

ER -